Astellas Unveils New, State-of-the-Art, $90 Million West Coast Innovation Center in the South San Francisco Biotech Corridor

– 154,000 square-foot lab and office facility creates a central location for Astellas’ West Coast cell and gene therapy research and business development operations TOKYO and SAN FRANCISCO, May 8, 2024 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura,…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks